The global Chronic Metabolic Disease Drug market was valued at 52370 million in 2024 and is projected to reach US$ 89930 million by 2031, at a CAGR of 8.2% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Metabolic Disease Drug manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Chronic Metabolic Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Metabolic Disease Drug. This report contains market size and forecasts of Chronic Metabolic Disease Drug in global, including the following market information:
Global Chronic Metabolic Disease Drug market revenue, 2020-2025, 2026-2031, ($ millions)
Global Chronic Metabolic Disease Drug market sales, 2020-2025, 2026-2031, (Tons)
Global top five Chronic Metabolic Disease Drug companies in 2024 (%)
Total Market by Segment:
Global Chronic Metabolic Disease Drug market, by Type, 2020-2025, 2026-2031 ($ millions) & (Tons)
Global Chronic Metabolic Disease Drug market segment percentages, by Type, 2024 (%)
Hypertension Drug
Hyperlipidemia Drug
High Blood Sugar Drug
High Uric Acid Drug
Global Chronic Metabolic Disease Drug market, by Application, 2020-2025, 2026-2031 ($ Millions) & (Tons)
Global Chronic Metabolic Disease Drug market segment percentages, by Application, 2024 (%)
Hospital
Clinic
Others
Global Chronic Metabolic Disease Drug market, by region and country, 2020-2025, 2026-2031 ($ millions) & (Tons)
Global Chronic Metabolic Disease Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Metabolic Disease Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Chronic Metabolic Disease Drug revenues share in global market, 2024 (%)
Key companies Chronic Metabolic Disease Drug sales in global market, 2020-2025 (estimated), (Tons)
Key companies Chronic Metabolic Disease Drug sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Daiichi Sankyo
Actelion Pharmaceuticals
Boehringer Ingelheim
Eli Lilly
Fresenius Kabi
Torrent Labs
Pfizer
Novo Nordisk
AstraZeneca plc
Regeneron Pharmaceuticals
GlaxoSmithKline plc
Merck & Co. Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Metabolic Disease Drug, market overview.
Chapter 2: Global Chronic Metabolic Disease Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Chronic Metabolic Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Metabolic Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chronic Metabolic Disease Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Chronic Metabolic Disease Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Chronic Metabolic Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Metabolic Disease Drug Overall Market Size
2.1 Global Chronic Metabolic Disease Drug Market Size: 2024 VS 2031
2.2 Global Chronic Metabolic Disease Drug Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Chronic Metabolic Disease Drug Sales: 2020-2031
3 Company Landscape
3.1 Top Chronic Metabolic Disease Drug Players in Global Market
3.2 Top Global Chronic Metabolic Disease Drug Companies Ranked by Revenue
3.3 Global Chronic Metabolic Disease Drug Revenue by Companies
3.4 Global Chronic Metabolic Disease Drug Sales by Companies
3.5 Global Chronic Metabolic Disease Drug Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Chronic Metabolic Disease Drug Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Chronic Metabolic Disease Drug Product Type
3.8 Tier 1, Tier 2, and Tier 3 Chronic Metabolic Disease Drug Players in Global Market
3.8.1 List of Global Tier 1 Chronic Metabolic Disease Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Metabolic Disease Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Chronic Metabolic Disease Drug Market Size Markets, 2024 & 2031
4.1.2 Hypertension Drug
4.1.3 Hyperlipidemia Drug
4.1.4 High Blood Sugar Drug
4.1.5 High Uric Acid Drug
4.2 Segment by Type - Global Chronic Metabolic Disease Drug Revenue & Forecasts
4.2.1 Segment by Type - Global Chronic Metabolic Disease Drug Revenue, 2020-2025
4.2.2 Segment by Type - Global Chronic Metabolic Disease Drug Revenue, 2026-2031
4.2.3 Segment by Type - Global Chronic Metabolic Disease Drug Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Chronic Metabolic Disease Drug Sales & Forecasts
4.3.1 Segment by Type - Global Chronic Metabolic Disease Drug Sales, 2020-2025
4.3.2 Segment by Type - Global Chronic Metabolic Disease Drug Sales, 2026-2031
4.3.3 Segment by Type - Global Chronic Metabolic Disease Drug Sales Market Share, 2020-2031
4.4 Segment by Type - Global Chronic Metabolic Disease Drug Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Chronic Metabolic Disease Drug Market Size, 2024 & 2031
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 Segment by Application - Global Chronic Metabolic Disease Drug Revenue & Forecasts
5.2.1 Segment by Application - Global Chronic Metabolic Disease Drug Revenue, 2020-2025
5.2.2 Segment by Application - Global Chronic Metabolic Disease Drug Revenue, 2026-2031
5.2.3 Segment by Application - Global Chronic Metabolic Disease Drug Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Chronic Metabolic Disease Drug Sales & Forecasts
5.3.1 Segment by Application - Global Chronic Metabolic Disease Drug Sales, 2020-2025
5.3.2 Segment by Application - Global Chronic Metabolic Disease Drug Sales, 2026-2031
5.3.3 Segment by Application - Global Chronic Metabolic Disease Drug Sales Market Share, 2020-2031
5.4 Segment by Application - Global Chronic Metabolic Disease Drug Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Chronic Metabolic Disease Drug Market Size, 2024 & 2031
6.2 By Region - Global Chronic Metabolic Disease Drug Revenue & Forecasts
6.2.1 By Region - Global Chronic Metabolic Disease Drug Revenue, 2020-2025
6.2.2 By Region - Global Chronic Metabolic Disease Drug Revenue, 2026-2031
6.2.3 By Region - Global Chronic Metabolic Disease Drug Revenue Market Share, 2020-2031
6.3 By Region - Global Chronic Metabolic Disease Drug Sales & Forecasts
6.3.1 By Region - Global Chronic Metabolic Disease Drug Sales, 2020-2025
6.3.2 By Region - Global Chronic Metabolic Disease Drug Sales, 2026-2031
6.3.3 By Region - Global Chronic Metabolic Disease Drug Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Chronic Metabolic Disease Drug Revenue, 2020-2031
6.4.2 By Country - North America Chronic Metabolic Disease Drug Sales, 2020-2031
6.4.3 United States Chronic Metabolic Disease Drug Market Size, 2020-2031
6.4.4 Canada Chronic Metabolic Disease Drug Market Size, 2020-2031
6.4.5 Mexico Chronic Metabolic Disease Drug Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Chronic Metabolic Disease Drug Revenue, 2020-2031
6.5.2 By Country - Europe Chronic Metabolic Disease Drug Sales, 2020-2031
6.5.3 Germany Chronic Metabolic Disease Drug Market Size, 2020-2031
6.5.4 France Chronic Metabolic Disease Drug Market Size, 2020-2031
6.5.5 U.K. Chronic Metabolic Disease Drug Market Size, 2020-2031
6.5.6 Italy Chronic Metabolic Disease Drug Market Size, 2020-2031
6.5.7 Russia Chronic Metabolic Disease Drug Market Size, 2020-2031
6.5.8 Nordic Countries Chronic Metabolic Disease Drug Market Size, 2020-2031
6.5.9 Benelux Chronic Metabolic Disease Drug Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Chronic Metabolic Disease Drug Revenue, 2020-2031
6.6.2 By Region - Asia Chronic Metabolic Disease Drug Sales, 2020-2031
6.6.3 China Chronic Metabolic Disease Drug Market Size, 2020-2031
6.6.4 Japan Chronic Metabolic Disease Drug Market Size, 2020-2031
6.6.5 South Korea Chronic Metabolic Disease Drug Market Size, 2020-2031
6.6.6 Southeast Asia Chronic Metabolic Disease Drug Market Size, 2020-2031
6.6.7 India Chronic Metabolic Disease Drug Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Chronic Metabolic Disease Drug Revenue, 2020-2031
6.7.2 By Country - South America Chronic Metabolic Disease Drug Sales, 2020-2031
6.7.3 Brazil Chronic Metabolic Disease Drug Market Size, 2020-2031
6.7.4 Argentina Chronic Metabolic Disease Drug Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Metabolic Disease Drug Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Chronic Metabolic Disease Drug Sales, 2020-2031
6.8.3 Turkey Chronic Metabolic Disease Drug Market Size, 2020-2031
6.8.4 Israel Chronic Metabolic Disease Drug Market Size, 2020-2031
6.8.5 Saudi Arabia Chronic Metabolic Disease Drug Market Size, 2020-2031
6.8.6 UAE Chronic Metabolic Disease Drug Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Chronic Metabolic Disease Drug Major Product Offerings
7.1.4 Novartis Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.1.5 Novartis Key News & Latest Developments
7.2 Daiichi Sankyo
7.2.1 Daiichi Sankyo Company Summary
7.2.2 Daiichi Sankyo Business Overview
7.2.3 Daiichi Sankyo Chronic Metabolic Disease Drug Major Product Offerings
7.2.4 Daiichi Sankyo Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.2.5 Daiichi Sankyo Key News & Latest Developments
7.3 Actelion Pharmaceuticals
7.3.1 Actelion Pharmaceuticals Company Summary
7.3.2 Actelion Pharmaceuticals Business Overview
7.3.3 Actelion Pharmaceuticals Chronic Metabolic Disease Drug Major Product Offerings
7.3.4 Actelion Pharmaceuticals Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.3.5 Actelion Pharmaceuticals Key News & Latest Developments
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Chronic Metabolic Disease Drug Major Product Offerings
7.4.4 Boehringer Ingelheim Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.4.5 Boehringer Ingelheim Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Chronic Metabolic Disease Drug Major Product Offerings
7.5.4 Eli Lilly Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Company Summary
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Chronic Metabolic Disease Drug Major Product Offerings
7.6.4 Fresenius Kabi Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.6.5 Fresenius Kabi Key News & Latest Developments
7.7 Torrent Labs
7.7.1 Torrent Labs Company Summary
7.7.2 Torrent Labs Business Overview
7.7.3 Torrent Labs Chronic Metabolic Disease Drug Major Product Offerings
7.7.4 Torrent Labs Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.7.5 Torrent Labs Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Chronic Metabolic Disease Drug Major Product Offerings
7.8.4 Pfizer Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.8.5 Pfizer Key News & Latest Developments
7.9 Novo Nordisk
7.9.1 Novo Nordisk Company Summary
7.9.2 Novo Nordisk Business Overview
7.9.3 Novo Nordisk Chronic Metabolic Disease Drug Major Product Offerings
7.9.4 Novo Nordisk Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.9.5 Novo Nordisk Key News & Latest Developments
7.10 AstraZeneca plc
7.10.1 AstraZeneca plc Company Summary
7.10.2 AstraZeneca plc Business Overview
7.10.3 AstraZeneca plc Chronic Metabolic Disease Drug Major Product Offerings
7.10.4 AstraZeneca plc Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.10.5 AstraZeneca plc Key News & Latest Developments
7.11 Regeneron Pharmaceuticals
7.11.1 Regeneron Pharmaceuticals Company Summary
7.11.2 Regeneron Pharmaceuticals Business Overview
7.11.3 Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Major Product Offerings
7.11.4 Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.11.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.12 GlaxoSmithKline plc
7.12.1 GlaxoSmithKline plc Company Summary
7.12.2 GlaxoSmithKline plc Business Overview
7.12.3 GlaxoSmithKline plc Chronic Metabolic Disease Drug Major Product Offerings
7.12.4 GlaxoSmithKline plc Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.12.5 GlaxoSmithKline plc Key News & Latest Developments
7.13 Merck & Co. Inc
7.13.1 Merck & Co. Inc Company Summary
7.13.2 Merck & Co. Inc Business Overview
7.13.3 Merck & Co. Inc Chronic Metabolic Disease Drug Major Product Offerings
7.13.4 Merck & Co. Inc Chronic Metabolic Disease Drug Sales and Revenue in Global (2020-2025)
7.13.5 Merck & Co. Inc Key News & Latest Developments
8 Global Chronic Metabolic Disease Drug Production Capacity, Analysis
8.1 Global Chronic Metabolic Disease Drug Production Capacity, 2020-2031
8.2 Chronic Metabolic Disease Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Metabolic Disease Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Metabolic Disease Drug Supply Chain Analysis
10.1 Chronic Metabolic Disease Drug Industry Value Chain
10.2 Chronic Metabolic Disease Drug Upstream Market
10.3 Chronic Metabolic Disease Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Metabolic Disease Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Chronic Metabolic Disease Drug in Global Market
Table 2. Top Chronic Metabolic Disease Drug Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Chronic Metabolic Disease Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Chronic Metabolic Disease Drug Revenue Share by Companies, 2020-2025
Table 5. Global Chronic Metabolic Disease Drug Sales by Companies, (Tons), 2020-2025
Table 6. Global Chronic Metabolic Disease Drug Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Chronic Metabolic Disease Drug Price (2020-2025) & (US$/Ton)
Table 8. Global Manufacturers Chronic Metabolic Disease Drug Product Type
Table 9. List of Global Tier 1 Chronic Metabolic Disease Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Metabolic Disease Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Chronic Metabolic Disease Drug Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Chronic Metabolic Disease Drug Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Chronic Metabolic Disease Drug Sales (Tons), 2020-2025
Table 15. Segment by Type - Global Chronic Metabolic Disease Drug Sales (Tons), 2026-2031
Table 16. Segment by Application – Global Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Chronic Metabolic Disease Drug Sales, (Tons), 2020-2025
Table 20. Segment by Application - Global Chronic Metabolic Disease Drug Sales, (Tons), 2026-2031
Table 21. By Region – Global Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Chronic Metabolic Disease Drug Sales, (Tons), 2020-2025
Table 25. By Region - Global Chronic Metabolic Disease Drug Sales, (Tons), 2026-2031
Table 26. By Country - North America Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Chronic Metabolic Disease Drug Sales, (Tons), 2020-2025
Table 29. By Country - North America Chronic Metabolic Disease Drug Sales, (Tons), 2026-2031
Table 30. By Country - Europe Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Chronic Metabolic Disease Drug Sales, (Tons), 2020-2025
Table 33. By Country - Europe Chronic Metabolic Disease Drug Sales, (Tons), 2026-2031
Table 34. By Region - Asia Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Chronic Metabolic Disease Drug Sales, (Tons), 2020-2025
Table 37. By Region - Asia Chronic Metabolic Disease Drug Sales, (Tons), 2026-2031
Table 38. By Country - South America Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Chronic Metabolic Disease Drug Sales, (Tons), 2020-2025
Table 41. By Country - South America Chronic Metabolic Disease Drug Sales, (Tons), 2026-2031
Table 42. By Country - Middle East & Africa Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Chronic Metabolic Disease Drug Sales, (Tons), 2020-2025
Table 45. By Country - Middle East & Africa Chronic Metabolic Disease Drug Sales, (Tons), 2026-2031
Table 46. Novartis Company Summary
Table 47. Novartis Chronic Metabolic Disease Drug Product Offerings
Table 48. Novartis Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 49. Novartis Key News & Latest Developments
Table 50. Daiichi Sankyo Company Summary
Table 51. Daiichi Sankyo Chronic Metabolic Disease Drug Product Offerings
Table 52. Daiichi Sankyo Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 53. Daiichi Sankyo Key News & Latest Developments
Table 54. Actelion Pharmaceuticals Company Summary
Table 55. Actelion Pharmaceuticals Chronic Metabolic Disease Drug Product Offerings
Table 56. Actelion Pharmaceuticals Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 57. Actelion Pharmaceuticals Key News & Latest Developments
Table 58. Boehringer Ingelheim Company Summary
Table 59. Boehringer Ingelheim Chronic Metabolic Disease Drug Product Offerings
Table 60. Boehringer Ingelheim Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 61. Boehringer Ingelheim Key News & Latest Developments
Table 62. Eli Lilly Company Summary
Table 63. Eli Lilly Chronic Metabolic Disease Drug Product Offerings
Table 64. Eli Lilly Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 65. Eli Lilly Key News & Latest Developments
Table 66. Fresenius Kabi Company Summary
Table 67. Fresenius Kabi Chronic Metabolic Disease Drug Product Offerings
Table 68. Fresenius Kabi Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 69. Fresenius Kabi Key News & Latest Developments
Table 70. Torrent Labs Company Summary
Table 71. Torrent Labs Chronic Metabolic Disease Drug Product Offerings
Table 72. Torrent Labs Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 73. Torrent Labs Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Chronic Metabolic Disease Drug Product Offerings
Table 76. Pfizer Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 77. Pfizer Key News & Latest Developments
Table 78. Novo Nordisk Company Summary
Table 79. Novo Nordisk Chronic Metabolic Disease Drug Product Offerings
Table 80. Novo Nordisk Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 81. Novo Nordisk Key News & Latest Developments
Table 82. AstraZeneca plc Company Summary
Table 83. AstraZeneca plc Chronic Metabolic Disease Drug Product Offerings
Table 84. AstraZeneca plc Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 85. AstraZeneca plc Key News & Latest Developments
Table 86. Regeneron Pharmaceuticals Company Summary
Table 87. Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Product Offerings
Table 88. Regeneron Pharmaceuticals Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 89. Regeneron Pharmaceuticals Key News & Latest Developments
Table 90. GlaxoSmithKline plc Company Summary
Table 91. GlaxoSmithKline plc Chronic Metabolic Disease Drug Product Offerings
Table 92. GlaxoSmithKline plc Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 93. GlaxoSmithKline plc Key News & Latest Developments
Table 94. Merck & Co. Inc Company Summary
Table 95. Merck & Co. Inc Chronic Metabolic Disease Drug Product Offerings
Table 96. Merck & Co. Inc Chronic Metabolic Disease Drug Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) & (2020-2025)
Table 97. Merck & Co. Inc Key News & Latest Developments
Table 98. Chronic Metabolic Disease Drug Capacity of Key Manufacturers in Global Market, 2023-2025 (Tons)
Table 99. Global Chronic Metabolic Disease Drug Capacity Market Share of Key Manufacturers, 2023-2025
Table 100. Global Chronic Metabolic Disease Drug Production by Region, 2020-2025 (Tons)
Table 101. Global Chronic Metabolic Disease Drug Production by Region, 2026-2031 (Tons)
Table 102. Chronic Metabolic Disease Drug Market Opportunities & Trends in Global Market
Table 103. Chronic Metabolic Disease Drug Market Drivers in Global Market
Table 104. Chronic Metabolic Disease Drug Market Restraints in Global Market
Table 105. Chronic Metabolic Disease Drug Raw Materials
Table 106. Chronic Metabolic Disease Drug Raw Materials Suppliers in Global Market
Table 107. Typical Chronic Metabolic Disease Drug Downstream
Table 108. Chronic Metabolic Disease Drug Downstream Clients in Global Market
Table 109. Chronic Metabolic Disease Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chronic Metabolic Disease Drug Product Picture
Figure 2. Chronic Metabolic Disease Drug Segment by Type in 2024
Figure 3. Chronic Metabolic Disease Drug Segment by Application in 2024
Figure 4. Global Chronic Metabolic Disease Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Chronic Metabolic Disease Drug Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Chronic Metabolic Disease Drug Revenue: 2020-2031 (US$, Mn)
Figure 8. Chronic Metabolic Disease Drug Sales in Global Market: 2020-2031 (Tons)
Figure 9. The Top 3 and 5 Players Market Share by Chronic Metabolic Disease Drug Revenue in 2024
Figure 10. Segment by Type – Global Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Chronic Metabolic Disease Drug Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Chronic Metabolic Disease Drug Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Chronic Metabolic Disease Drug Price (US$/Ton), 2020-2031
Figure 14. Segment by Application – Global Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Chronic Metabolic Disease Drug Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Chronic Metabolic Disease Drug Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Chronic Metabolic Disease Drug Price (US$/Ton), 2020-2031
Figure 18. By Region – Global Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Chronic Metabolic Disease Drug Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Chronic Metabolic Disease Drug Revenue Market Share, 2020-2031
Figure 21. By Region - Global Chronic Metabolic Disease Drug Sales Market Share, 2020-2031
Figure 22. By Country - North America Chronic Metabolic Disease Drug Revenue Market Share, 2020-2031
Figure 23. By Country - North America Chronic Metabolic Disease Drug Sales Market Share, 2020-2031
Figure 24. United States Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Chronic Metabolic Disease Drug Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Chronic Metabolic Disease Drug Sales Market Share, 2020-2031
Figure 29. Germany Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 30. France Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Chronic Metabolic Disease Drug Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Chronic Metabolic Disease Drug Sales Market Share, 2020-2031
Figure 38. China Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 42. India Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Chronic Metabolic Disease Drug Revenue Market Share, 2020-2031
Figure 44. By Country - South America Chronic Metabolic Disease Drug Sales, Market Share, 2020-2031
Figure 45. Brazil Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Chronic Metabolic Disease Drug Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Chronic Metabolic Disease Drug Sales, Market Share, 2020-2031
Figure 49. Turkey Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Chronic Metabolic Disease Drug Revenue, (US$, Mn), 2020-2031
Figure 53. Global Chronic Metabolic Disease Drug Production Capacity (Tons), 2020-2031
Figure 54. The Percentage of Production Chronic Metabolic Disease Drug by Region, 2024 VS 2031
Figure 55. Chronic Metabolic Disease Drug Industry Value Chain
Figure 56. Marketing Channels
